The media reports of national COVID-19 statistics mask the substantial and continuing variations among regions. The virus doesn't care about geography, but we need to understand geographic differences if it is to be contained.
Search results
Our friendly neighbors to the north are fibbing about the coronavirus in their country, justifying a border closure with the United States that no longer makes sense.
Europe is in worse shape than the U.S. when it comes to new infections, at least for the time being. Without a change in strategy -- and hoping for a vaccine is not a strategy -- going back into lockdown is pointless, as a third (or fourth) wave will emerge when society reopens.
Kelsey Grammer is poised, quick witted, has a good sense of humor, and carries an aura of intellectual authority. He should be the next Jeopardy! host.
A writing partnership, between a University of Maryland professor and the pharmaceutical expert at the American Council on Science and Health, continues to thrive, producing valuable health information for publication in a major national newspaper.
Every year Livermore National Laboratory produces a chart of where our energy comes from and where it goes. The biggest changes, less coal, more natural gas.
From Stat, "Health care workers in the UK are seven times likelier to fall ill with severe Covid-19 than the rest of the population, according to a large new study." The statement is factual; it's just without a context. It is far scarier than need be.
The governor of Washington State has canceled Thanksgiving, Christmas, and New Year's, and about 20% of Seattle's restaurants and bars have closed permanently. The governor's arbitrary policies, such as banning indoor dining while allowing customers to eat inside tents, deserve part of the blame. Photographs put the absurdity on stark display.
The war against the "infodemic" ... why are we drawn to conspiracy ... what if we could save ourselves from climate change -- but had to use GMOs ... doodles from a lockdown ... and in the seasonal spirit, the economy that is Christmas Trees.
Even in the time of COVID-19, antibiotic resistance remains a problem. Is it a particle or a wave? - turns out it may be neither. Zombies get all the press, but are vampires the real problem? Theory or practice? Finally, more on the science of gift-giving.
COVID-19 infections are relentless. In every state, November rates increased over October, more than doubling on average. And these rates are widely dispersed across the nation. Early COVID-19 cases and deaths were associated with local conditions, including residential crowding and household income. More personal factors have since come into play as the pandemic spread and hotspots shifted to the heartland.
We, humans, have difficulty understanding the very small and the very large, but scale plays an increasingly important role in our lives - think Amazon or Twitter. What if we taught about scale in school? Are we becoming more or less violent? An update on COVID-19's origin story - a cautionary tale? What does the Federal Trade Commission have to do with the problems at the Capital?
This monthly report presents systematic descriptions for the U.S.'s six geographic regions using state-level [1] COVID-19 cases based on positive tests, subsequent deaths, and case-fatality ratios (CFRs).
Back in August, the FDA issued an Emergency Use Authorization for convalescent plasma for treating those with COVID-19. With more data in hand, the agency has now limited its use to a subset of hospitalized patients.
We’ve all heard the “heartbreaking” stories – the passing of a loved one is met with the passing of their spouse soon thereafter. Are these sudden, paired deaths only coincidences – or is there a medical basis such that one can literally die from a broken heart?
The Trump Administration has sought to change how we review scientific studies used in regulatory decisions. Those changes have caused quite a bit of controversy, and now the Courts have sent it back to the EPA to "redo."
CDC policymaking is coming up short, according to Henry Miller, M.D., and John J. Cohrssen. The agency continues to relegate policymaking to value judgments instead of hard data.
COVID-19 frequently dominates the nightly news, and it’s always there in today’s daily life. Is the pandemic ebbing, or is it still menacing the careless? Charts, tables, and statistics dominate the discussion. Some emphasize counts, some quote short-term percentage changes like a 20% drop. Pictures and statistics tell stories, but with COVID-19, it depends on how you look at them.
Let’s not forget that the goal in tamping down the COVID-19 pandemic is to vaccinate the world. But it’s an ambitious project impaired by the concepts of “vaccine nationalism,” fostered by “vaccine diplomacy.” We should consider more than how those words make us feel.
It took only a few days for the American Federation of Teachers, their second-largest union, to say “not so fast” to the CDC’s recommendation for opening schools by reducing pupils' distance from six to three feet. What is the science behind their concerns?
The DEA lifted its 2007 ban on methadone clinics sending out mobile units to reach people in communities underserved by the clinics. But patients are required to take the methadone in the presence of clinic staff. A better solution is to let doctors prescribe take-home methadone, like they do in Canada, UK, Australia--and they were permitted to do as an emergency measure during the pandemic.
New COVID-19 cases (infections) and deaths began a steep decline in January, followed by deaths and case-fatality rates a few weeks later. What are the sources of the variability we identified in our national regions?
The FDA’s controversial approval of Aduhelm, the drug intended to treat Alzheimer’s Disease, has resulted in resignations from their advisory committee and now investigations, both internal and Congressional. The FDA and editors of JAMA Internal Medicine are speaking out before the investigational circus comes to town.
The complications of being hospitalized with COVID-19 may increase your chances of dying, and in many cases leave you more debilitated than before becoming ill. There is more to COVID-19's recovery than those with "long COVID."
CMS provides a twice-annual snapshot of the care and concerns of Medicare beneficiaries. They just released the latest survey that ended in April. We have time to take in a few curated highlights.
Pagination
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!